{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:36:20Z","timestamp":1787070980983,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Neonatal seizure (NS) reflects serious underlying brain injury, requiring immediate evaluation and early treatment. In neonates, phenobarbitone and phenytoin are used primarily to control the seizures. If uncontrolled, widespread off-label use of midazolam and levetiracetam was practiced. These drugs gained popularity though there are no such studies available on literature search comparing them. The present study was designed to explore these lacunae using these two drugs in refractory cases. To study the efficacy and adverse drug reactions (ADRs) of midazolam and levetiracetam not responding to usual line of therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>This was a prospective cross-sectional study conducted on 69 neonates in the NICU and Department of Pharmacology in Burdwan Medical College and Hospital, West Bengal. Patients receiving midazolam or levetiracetam when uncontrolled with first line antiepileptics, namely, phenobarbitone and phenytoin, were considered eligible. The study variables were time to control seizure, seizure recurrence and frequency, and treatment-related adverse events. analysis used Mann\u2013Whitney U-test were applied Comparison with respect to time to control and Chi-square test were applied to detect difference in proportion for ADRs. The SPSS Statistics 17.0 was used for analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      We compared the time periods to control neonatal seizure for effectiveness between levetiracetam and midazolam showing no significant difference (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.190). Comparing the portion of recurrences in two groups gives statistically nonsignificant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.878) result. Only respiratory depression was seen in the levetiracetam group (12.90%) and midazolam group (18.42%). All adverse events were 'probable\u2019 as per the WHO-UMC criteria, and there was no statistically significant difference between the two drugs (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.533).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Both midazolam and levetiracetam are equally effective and safe in NS not responding to usual line of treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jehp.jehp_937_20","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T12:47:54Z","timestamp":1713876474000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness and adverse drug reactions of levetiracetam and midazolam in refractory neonatal seizure: A cross-sectional comparative study"],"prefix":"10.4103","volume":"10","author":[{"given":"Diptiman","family":"Jayswal","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Burdwan Medical College and Hospital, Bardhaman, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uttam Kumar","family":"Roy","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Raiganj Government Medical College and Hospital, Raiganj, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taraknath","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Burdwan Medical College and Hospital, Bardhaman, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purnendu","family":"Mandal","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Raiganj Government Medical College and Hospital, Raiganj, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,3]]},"reference":[{"key":"R2-20250921","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1542\/peds.2005-1178","article-title":"The current etiologic profile and neurodevelopmental outcome of seizures in term newborn infants","volume":"117","author":"Tekgul","year":"2006","journal-title":"Pediatrics"},{"key":"R3-20250921","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000494702","article-title":"Incidence of Epilepsy after Neonatal Seizures: A Population-Based Study","volume":"52","author":"Andreolli","year":"2019","journal-title":"Neuroepidemiology"},{"issue":"suppl 7","key":"R4-20250921","first-page":"102","article-title":"Neurologic impairment, developmental delay and post-natal seizures two-years after video-EEG documented seizures in near-term and full-term neonates: report of the Clinical Research Centers for Neonatal Seizures","volume":"42","author":"Mizrahi","year":"2001","journal-title":"Epilepsia"},{"key":"R5-20250921","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pediatrneurol.2003.09.015","article-title":"Risk factors for developing epiliepsy after neonatal seizures","volume":"30","author":"Da Silva","year":"2004","journal-title":"Pediatr Neurol"},{"key":"R6-20250921","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.siny.2013.05.008","article-title":"Epidemiology and aetiology of neonatal seizures","volume":"18","author":"Vasudevan","year":"2013","journal-title":"Semin Fetal Neonatal Med"},{"key":"R7-20250921","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.pediatrneurol.2008.03.003","article-title":"Neonatal seizures: Dilemmas in workup and management","volume":"38","author":"Bassan","year":"2008","journal-title":"Pediatr Neurol"},{"key":"R8-20250921","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pediatrneurol.2007.04.003","article-title":"Neonatal seizures: multicenter variability in current treatment practices","volume":"37","author":"Bartha","year":"2007","journal-title":"Pediatr Neurol"},{"key":"R9-20250921","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12887-019-1508-5","article-title":"Etiology of neonatal seizures and maintenance therapy use: A 10-year retrospective study at Toulouse Children's hospital","volume":"19","author":"Baudou","year":"2019","journal-title":"BMC Pediatr"},{"key":"R10-20250921","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4172\/2167-0897.1000226","article-title":"Phenobarbitone in neonatal seizures: Controversies","volume":"5","author":"Gupta","year":"2016","journal-title":"J Neonatal Biol"},{"issue":"6","key":"R11-20250921","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s40265-016-0554-7","article-title":"Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives","volume":"76","author":"Donovan","year":"2016","journal-title":"Drugs"},{"key":"R12-20250921","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3389\/fneur.2019.00506","article-title":"A Comparison of parenteral phenobarbital vs. parenteral phenytoin as second-line management for pediatric convulsive status epilepticus in a resource-limited setting","volume":"10","author":"Burman","year":"2019","journal-title":"Front Neurol"},{"key":"R14-20250921","doi-asserted-by":"crossref","first-page":"309342","DOI":"10.1155\/2014\/309342","article-title":"Clinical pharmacology of midazolam in neonates and children: Effect of disease-a review","volume":"2014","author":"Pacifici","year":"2014","journal-title":"Int J Pediatr"},{"key":"R16-20250921","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/ped.13554","article-title":"Midazolam as a first-line treatment for neonatal seizures: Retrospective study","volume":"60","author":"Dao","year":"2018","journal-title":"Pediat Int"},{"key":"R17-20250921","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/0883073810384263","article-title":"Levetiracetam for treatment of neonatal seizures","volume":"26","author":"Abend","year":"2011","journal-title":"J Child Neurol"},{"key":"R18-20250921","first-page":"295","article-title":"Safety and efficacy of levetiracetam for the treatment of partial onset seizures in children from one month of age","volume":"9","author":"Cormier","year":"2013","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R19-20250921","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2008.04.008","article-title":"Off-label use of antiepileptic drugs for the treatment of neonatal seizures","volume":"39","author":"Silverstein","year":"2008","journal-title":"Pediatr Neurol"},{"key":"R23-20250921","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.siny.2013.01.001","article-title":"Treatment of neonatal seizures","volume":"18","author":"van Rooij","year":"2013","journal-title":"Semin Fetal Neonatal Med"},{"key":"R24-20250921","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/0883073807313041","article-title":"Successful management of refractory neonatal seizures with Midazolam","volume":"23","author":"Sirsi","year":"2008","journal-title":"J Child Neurol"},{"key":"R25-20250921","doi-asserted-by":"crossref","first-page":"e0173539","DOI":"10.1371\/journal.pone.0173539","article-title":"Pre-hospital midazolam for benzodiazepine-treated seizures before and after the Rapid Anticonvulsant Medication Prior to Arrival Trial: A national observational cohort study","volume":"12","author":"Shtull-Leber","year":"2017","journal-title":"PLoS One"},{"issue":"Suppl 8","key":"R26-20250921","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1528-1167.2011.03235.x","article-title":"RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): A double-blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedics","volume":"52","author":"Silbergleit","year":"2011","journal-title":"Epilepsia"},{"key":"R27-20250921","first-page":"5","article-title":"Etiology and management of neonatal seizures-successful treatment by midazolam","volume":"38","author":"Kawaguchi","year":"2006","journal-title":"No To Hattatsu"},{"key":"R28-20250921","first-page":"279","article-title":"Continuous midazolam infusion in the treatment of uncontrollable neonatal seizures","volume":"44","author":"Hu","year":"2003","journal-title":"Acta Paediatr Taiwan"},{"key":"R29-20250921","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1212\/01.WNL.0000152891.58694.71","article-title":"Midazolam in neonatal seizures with no response to phenobarbital","volume":"64","author":"Castro Conde","year":"2005","journal-title":"Neurology"},{"key":"R30-20250921","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pediatrneurol.2010.11.005","article-title":"Use of intravenous levetiracetam for management of acute seizures in neonates","volume":"44","author":"Khan","year":"2011","journal-title":"Pediatr Neurol"},{"key":"R31-20250921","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.yebeh.2018.09.015","article-title":"A comparison of levetiracetam and phenobarbital for the treatment of neonatal seizures associated with hypoxic-ischemic encephalopathy","volume":"88","author":"Rao","year":"2018","journal-title":"Epilepsy Behav"},{"key":"R32-20250921","doi-asserted-by":"crossref","first-page":"3683548","DOI":"10.1155\/2019\/3683548","article-title":"Short-term neurodevelopmental outcome in term neonates treated with phenobarbital versus levetiracetam: A single-center experience","volume":"2019","author":"Falsaperla","year":"2019","journal-title":"Behav Neurol"},{"key":"R33-20250921","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.seizure.2010.01.003","article-title":"Levetiracetam in the treatment of neonatal seizures: A pilot study","volume":"19","author":"F\u00fcrwentsches","year":"2010","journal-title":"Seizure"},{"key":"R34-20250921","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1756285608100460","article-title":"New treatment options in status epilepticus: A critical review on intravenous levetiracetam","volume":"2","author":"Trinka","year":"2009","journal-title":"Ther Adv Neurol Disord"},{"issue":"11","key":"R35-20250921","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/jp.2013.116","article-title":"Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures","volume":"33","author":"Maitre","year":"2013","journal-title":"J Perinatol"},{"key":"R36-20250921","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/jpn.JPN_172_16","article-title":"Levetiracetam in neonatal seizures as first-line treatment: A prospective study","volume":"12","author":"Falsaperla","year":"2017","journal-title":"J Pediatr Neurosci"}],"container-title":["Journal of Education and Health Promotion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jehp.jehp_937_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:39:55Z","timestamp":1787067595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jehp.jehp_937_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jehp.jehp_937_20","relation":{},"ISSN":["2277-9531","2319-6440"],"issn-type":[{"value":"2277-9531","type":"print"},{"value":"2319-6440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"2020-08-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}